Non-invasive urine-based diagnostic test that analyzes asparagine-linked carbohydrates of PSA to detect prostate cancer and assess disease aggressiveness. The assay provides comprehensive N-glycomic profiling in a single test, reducing false positives and unnecessary clinical interventions.
Manufactured by
Veszprém, Hungary
iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and patient-friendly worldwide , with upcoming launches in Europe and the U.S. in collaboration with Mayo Clinic .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zybio Inc.
China · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Berkeley Health Ltd
United Kingdom · 2 relevant products
Diagnostics Biochem Canada Inc.
Canada · 2 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
YASEE BioMedical Inc.
China · 2 relevant products
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 101 closest product alternatives
Zybio Inc. · China
Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.
BEACON DIAGNOSTICS PVT. LTD. · India
Prostate-specific antigen assay for screening and monitoring of prostate cancer. Quantitative measurement of PSA in serum samples.
Shenzhen Microprofit Biotech Co., Ltd · China
FIA-based quantitative test kit for PSA measurement in prostate health screening. Designed for point-of-care testing applications.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of free prostate specific antigen in human serum samples. The assay has an assay time of 75 minutes, a shelf stability of 18 months, and a sensitivity of 0.05 ng/mL. Reference: CAN-FPSA-4400.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A lateral flow immunoassay test kit for detection of prostate-specific antigen levels. This test aids in prostate health screening and early detection of abnormalities.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of total prostate specific antigen in human serum samples. The assay has an assay time of 105 minutes, a shelf stability of 12 months, and a sensitivity of 0.1 ng/mL. Reference: CAN-TPSA-4300.
YASEE BioMedical Inc. · China
Point-of-care diagnostic test for urinalysis including detection of glucose, protein, and other metabolites. Suitable for rapid screening in clinical and community settings.
J. Mitra & Co. Pvt. Ltd. · India
Chemiluminescence immunoassay for total prostate-specific antigen measurement with analytical sensitivity of 0.005 ng/ml and linearity up to 100 ng/ml.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence test kit for simultaneous detection of AFP, CEA, and total PSA biomarkers. Used for cancer screening and monitoring in clinical laboratories and point-of-care settings. Provides rapid quantitative results for liver, colorectal, and prostate cancer assessment.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
Hangzhou AllTest Biotech Co.,Ltd · China
Rapid immunochromatographic test kit for simultaneous detection of HIV 1/2 antibodies and PSA antigen in whole blood, serum, or plasma. Delivers results within 10-15 minutes, enabling point-of-care screening in clinical and field settings. Single-use cassette format with high sensitivity and specificity for reliable diagnostic outcomes.
89 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products